| Literature DB >> 32354112 |
Thanh Ninh Le1, Napat Sakulsataporn1, Chiu-Hsia Chiu1, And Pao-Chuan Hsieh1.
Abstract
Broccoli contains a substantial amount of bioactive compounds such as glucosinolates, phenolics, and essential nutrients, which are positively linked to health-promoting effects. This work aimed to evaluate whether both edible and non-edible parts of broccoli could be effective by examining in vitro antioxidant, cytotoxic, apoptotic, and antibacterial properties of its floret, leaf, and seed extracts (FE, LE, and SE, correspondingly). High-performance liquid chromatography (HPLC) and various assays exhibited strong antioxidant activities of all samples. LE obtained the highest capacity, correlated to its polyphenolic contents. SE exerted significant cytotoxicity against A549, Caco-2, and HepG2 cancer cell lines at low inhibitory concentration (IC)50 values (0.134, 0.209, and 0.238 mg/mL, respectively), as tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Flow cytometry confirmed apoptosis induction of extracts in Caco-2 cells by revealing an increased subG1 population and a decreased mitochondrial membrane potential. The considerable antibacterial efficacy was observed in either LE and SE against Bacillus subtilis and Salmonella typhimurium (0.39-0.78 mg/mL) using well-agar diffusion and minimum inhibitory concentration (MIC) techniques, along with the weak activity against Staphylococcus aureus and Escherichia coli (1.56-3.13 mg/mL). The findings suggest that broccoli and its byproducts might serve as a promising source for further development of food or pharmaceutical products.Entities:
Keywords: antibacterial activity; antioxidant activity; apoptosis; broccoli; byproducts; cytotoxicity
Year: 2020 PMID: 32354112 PMCID: PMC7280965 DOI: 10.3390/ph13050082
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Antioxidant activity of edible and non-edible parts of broccoli.
| Broccoli Parts | DPPH Scavenging Activity (Inhibition %) | Reducing Power Absorbance (700 nm) | ABTS Scavenging Activity (µmol TE/g DW) |
|---|---|---|---|
| FE | |||
| 70% Methanol | 79.95 ± 2.63 bA | 1.04 ± 0.05 bB | 67.81 ± 0.17 aA |
| 70% Ethanol | 79.37 ± 2.97 cA | 1.21 ± 0.03 cA | 67.92 ± 0.10 aA |
| Hot water | 58.21 ± 4.91 bB | 0.55 ± 0.07 cC | 43.06 ± 1.80 bB |
| LE | |||
| 70% Methanol | 81.64 ± 1.90 bA | 1.70 ± 0.02 aB | 68.23 ± 0.30 aA |
| 70% Ethanol | 85.41 ± 1.32 bA | 1.79 ± 0.04 aA | 68.05 ± 0.25 aA |
| Hot water | 61.06 ± 9.15 bB | 0.84 ± 0.04 bC | 62.46 ± 0.87 aB |
| SE | |||
| 70% Methanol | 90.86 ± 0.65 aA | 1.65 ± 0.13 aA | 66.90 ± 0.27 bA |
| 70% Ethanol | 92.13 ± 0.45 aA | 1.67 ± 0.06 bA | 68.51 ± 0.35 aA |
| Hot water | 79.53 ± 6.22 aB | 1.27 ± 0.05 aB | 64.77 ± 1.04 aB |
| Ascorbic acid * | 96.31 ± 1.08 | 2.59 ± 0.04 | 66.86 ± 0.21 |
DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2’-azino-bis-3-ethylbenzothiazoline-6-sulphonic; TE, Trolox equivalent; DW, dried weight; FE, floret extract; LE, leaf extract; SE, seed extract. * Positive control included (0.5 mg/mL). Data are expressed as mean values ± SD of triplicate experiments (n = 3). The a, b, c lowercase letters indicate significant differences between broccoli parts, and the A, B, C uppercase letters indicate significant differences between solvents at p ≤ 0.05.
Antioxidant properties of edible and non-edible parts of broccoli.
| Broccoli Parts | Total Phenolic Content (mg GAE/g DW) | Total Flavonoid Content (mg CE/g DW) | Vitamin C Content (mg AA/g DW) |
|---|---|---|---|
| FE | |||
| 70% Methanol | 20.78 ± 1.09 bA | 5.32 ± 0.08 bB | 2.54 ± 0.35 aA |
| 70% Ethanol | 19.50 ± 0.79 bA | 6.33 ± 0.21 bA | 2.50 ± 0.32 aA |
| Hot water | 15.35 ± 0.58 bB | 2.84 ± 0.13 cC | 1.66 ± 0.10 bB |
| LE | |||
| 70% Methanol | 28.50 ± 0.38 aA | 8.71 ± 0.16 aB | 2.92 ± 0.28 aA |
| 70% Ethanol | 25.77 ± 0.37 aB | 9.93 ± 0.43 aA | 2.31 ± 0.10 aB |
| Hot water | 24.79 ± 0.32 aC | 7.84 ± 0.21 aC | 2.74 ± 0.12 aAB |
| SE | |||
| 70% Methanol | 16.55 ± 1.01 cA | 3.74 ± 0.10 cA | 2.69 ± 0.28 aA |
| 70% Ethanol | 15.96 ± 0.87 cA | 3.51 ± 0.11 cA | 2.25 ± 0.39 aA |
| Hot water | 12.58 ± 0.54 cB | 3.59 ± 0.15 bA | 1.98 ± 0.33 bA |
GAE, gallic acid equivalent; CE, catechin acid equivalent; AA, ascorbic acid equivalent; the a, b, c lowercase letters indicate significant differences between broccoli parts, and the A, B, C uppercase letters indicate significant differences between solvents (p ≤ 0.05, n = 3).
Levels of phenolic compounds in edible and non-edible parts of broccoli.
| Phenolic Compounds (mg/g Extract) | FE | LE | SE |
|---|---|---|---|
| Gallic acid | 0.526 ± 0.048 a | 0.150 ± 0.002 b | 0.165 ± 0.013 b |
| Esculetin | 4.573 ± 0.184 c | 6.488 ± 0.309 b | 10.179 ± 0.251 a |
| Caffeic acid | 0.795 ± 0.019 a | ND | 0.121 ± 0.008 b |
| Ferulic acid | 1.321 ± 0.087 a | 0.239 ± 0.003 c | 0.580 ± 0.016 b |
| Myricetin | 0.327 ± 0.004 b | 2.768 ± 0.129 a | 0.309 ± 0.014 b |
| Quercerin | 0.575 ± 0.003 b | 0.972 ± 0.017 a | 0.563 ± 0.016 b |
ND, not detected; the a, b, c lowercase letters indicate significant differences between broccoli parts (p ≤ 0.05, n = 3).
Cytotoxic activity of edible and non-edible parts of broccoli.
| Broccoli Parts | IC50 (mg/mL) * | |||
|---|---|---|---|---|
| HepG2 | A549 | Caco-2 | FL83B | |
| FE | ||||
| 24 h | 0.443 ± 0.048 aA | 0.318 ± 0.075 aA | 0.417 ± 0.039 aA | >0.500 |
| 48 h | 0.306 ± 0.052 aB | 0.184 ± 0.022 abA | 0.295 ± 0.032 bB | >0.500 |
| LE | ||||
| 24 h | 0.478 ± 0.026 aC | 0.257 ± 0.038 aA | 0.391 ± 0.015 aB | >0.500 |
| 48 h | 0.267 ± 0.090 aA | 0.191 ± 0.025 bA | 0.254 ± 0.013 abA | >0.500 |
| SE | ||||
| 24 h | >0.500 | 0.271 ± 0.032 aA | 0.420 ± 0.035 aB | >0.500 |
| 48 h | 0.238 ± 0.031 aB | 0.134 ± 0.017 aA | 0.209 ± 0.016 aB | >0.500 |
| Cisplatin | ||||
| 24 h | 0.019 ± 0.001 | 0.009 ± 0.001 | 0.023 ± 0.002 | >0.050 |
| 48 h | 0.015 ± 0.003 | <0.006 | 0.007 ± 0.003 | 0.027 ± 0.005 |
* IC50, a concentration in two-fold serial dilutions of extracts (0.063–0.500 mg/mL), which reduced cell growth by 50% after 24 and 48 h of treatment. HepG2, hepatocellular carcinoma cells; A549, lung carcinoma cells; Caco-2, colorectal adenocarcinoma cells; FL83B, normal liver cells. Cisplatin was referentially used as a positive control (0.006–0.050 mg/mL). The a, b lowercase letters indicate significant differences between broccoli parts at the same incubation time, and the A, B, C uppercase letters indicate significant differences between cell lines (p ≤ 0.05, n = 3).
Figure 1Cell cycle distribution at different phases (SubG1, G0/G1, S, and G2/M) of Caco-2 cells treated with extracts (0.20 mg/mL) and cisplatin (0.02 mg/mL) for 24 and 48 h and analyzed using flow cytometry after staining with PI (propidium iodide). Cis, cisplatin; Con, control (untreated cells). FE, floret extract; LE, leaf extract; SE, seed extract.
Figure 2The changes of the mitochondrial membrane potential (ΔΨ) level in Caco-2 cells treated with broccoli extracts (0.20 mg/mL) and cisplatin (0.02 mg/mL) for various time points and analyzed using flow cytometry after staining with DiOC6 (3,3′-dihexyloxacarbocyanine iodide).
Antibacterial activity of edible and non-edible parts of broccoli.
| Bacterial Strains | Diameter of the Inhibition Zones (mm) * | |||||
|---|---|---|---|---|---|---|
| FE | LE | SE | Amp | Amo | D20 | |
| Gram-positive | ||||||
|
| 15.24 ± 0.40 bC | 17.16 ± 0.50 aB | 14.46 ± 0.45 bC | 36.38 ± 0.76 | 33.76 ± 0.56 | ND |
|
| 26.79 ± 0.81 aA | 24.04 ± 0.66 bA | 25.81 ± 0.48 aA | 38.10 ± 0.75 | 37.33 ± 1.39 | ND |
| Gram-negative | ||||||
|
| 16.13 ± 0.25 aC | 16.20 ± 0.43 aB | 14.85 ± 0.64 bC | 39.04 ± 0.87 | 36.00 ± 0.60 | ND |
|
| 24.88 ± 0.92 aB | 23.51 ± 0.93 abA | 22.71 ± 0.32 bB | 43.54 ± 0.19 | 40.84 ± 0.47 | ND |
* Diameter of the inhibition zones (included 9 mm of well diameter) of broccoli extracts (50 mg/mL), positive controls: Amp, ampicillin; Amo, amoxicillin (0.1 mg/mL); negative control: D20, 20% DMSO (dimethyl sulfoxide). S. aureus, Staphylococcus aureus; B. subtilis, Bacillus subtilis; S. typhimurium, Salmonella typhimurium; E. coli, Escherichia coli. ND, not detected. The a, b lowercase letters indicate significant differences between broccoli parts, and the A, B, C uppercase letters indicate significant differences between strains (p ≤ 0.05, n = 3).
Minimum inhibitory concentration (MIC) of edible and non-edible parts of broccoli.
| Bacterial Strains | MIC (mg/mL) * | Control | ||||
|---|---|---|---|---|---|---|
| FE | LE | SE | Amp | Amo | NT | |
| Gram-positive | ||||||
|
| 1.56 | 1.56 | 3.13 | − | − | + |
|
| 0.78 | 0.78 | 0.39 | − | − | + |
| Gram-negative | ||||||
|
| 3.13 | 3.13 | 3.13 | − | − | + |
|
| 1.56 | 0.78 | 1.56 | − | − | + |
* The MIC values were recorded in multiple two-fold dilutions of extracts (0.1–50 mg/mL). Positive controls: Amp, ampicillin; Amo, amoxicillin (0.1 mg/mL); negative control: NT, not treated by antibiotics or extracts. −, no bacterial growth; +, bacterial growth.